|
1
|
Svoboda J, Armand P, Porcu P, Burke J, Stevens D, Moezi M, Bajaj M, Cull E, Wan Y, Duan C, Forslund A, Gajavelli S, Yasenchak C. TREATMENT PATTERNS, CLINICAL OUTCOMES, AND BIOMARKER EVALUATION IN CLASSICAL HODGKIN LYMPHOMA: A PROSPECTIVE OBSERVATIONAL STUDY IN US ONCOLOGY PRACTICES. Hematol Oncol 2019. [DOI: 10.1002/hon.165_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- J. Svoboda
- Lymphoma Program; University of Pennsylvania; Philadelphia United States
| | - P. Armand
- Department of Medical Oncology; Dana-Farber Cancer Institute; Boston United States
| | - P. Porcu
- Division of Medical Oncology and Hematopoietic Stem Cell Transplantation; Sidney Kimmel Cancer Center, Thomas Jefferson University; Philadelphia United States
| | - J.M. Burke
- Medical Oncology / Hematology; Rocky Mountain Cancer Centers; Aurora United States
| | - D. Stevens
- Hematology and Medical Oncology; Norton Cancer Institute; Louisville United States
| | - M. Moezi
- Medical Oncology; Hematology and Internal Medicine, Cancer Specialists of North Florida; Fleming Island United States
| | - M. Bajaj
- Medical Oncology; Illinois Cancer Care; Peoria United States
| | - E.H. Cull
- Hematology/Oncology; Greenville Health System; Greenville United States
| | - Y. Wan
- Center for Observational Research; Bristol-Myers Squibb; Princeton United States
| | - C. Duan
- Moffitt Cancer Center; Bristol-Myers Squibb; Princeton United States
| | - A. Forslund
- Precision Medicine and Translational Research in Oncology; Bristol-Myers Squibb; Princeton United States
| | | | - C. Yasenchak
- Medical Oncology and Hematology; Willamette Valley Cancer Institute and Research Center/US Oncology Research; Eugene United States
| |
Collapse
|
|
2
|
Yasenchak C, Nackaerts K, Awada A, Gadgeel S, Hellerstedt B, Perry M, Richards D, Yang C, Scheffold C, Lara P. 397 Phase 2 results of XL184 in a cohort of patients (pts) with advanced non-small cell lung cancer (NSCLC). EJC Suppl 2010. [DOI: 10.1016/s1359-6349(10)72104-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|